346 related articles for article (PubMed ID: 38424512)
1. Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.
Schiavoni G; Messina B; Scalera S; Memeo L; Colarossi C; Mare M; Blandino G; Ciliberto G; Bon G; Maugeri-Saccà M
J Transl Med; 2024 Feb; 22(1):213. PubMed ID: 38424512
[TBL] [Abstract][Full Text] [Related]
2. Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression.
Messina B; Lo Sardo F; Scalera S; Memeo L; Colarossi C; Mare M; Blandino G; Ciliberto G; Maugeri-Saccà M; Bon G
Cell Death Dis; 2023 Jan; 14(1):21. PubMed ID: 36635265
[TBL] [Abstract][Full Text] [Related]
3. Role of the Hippo pathway and mechanisms for controlling cellular localization of YAP/TAZ.
Kwon H; Kim J; Jho EH
FEBS J; 2022 Oct; 289(19):5798-5818. PubMed ID: 34173335
[TBL] [Abstract][Full Text] [Related]
4. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
Zhu J; Wu T; Lin Q
Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
[TBL] [Abstract][Full Text] [Related]
5. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
6. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
Budel SJ; Penning MM; Penning LC
Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective.
Samji P; Rajendran MK; Warrier VP; Ganesh A; Devarajan K
Cell Signal; 2021 Feb; 78():109858. PubMed ID: 33253912
[TBL] [Abstract][Full Text] [Related]
8. Identification of PTPN12 Phosphatase as a Novel Negative Regulator of Hippo Pathway Effectors YAP/TAZ in Breast Cancer.
Sarmasti Emami S; Ge A; Zhang D; Hao Y; Ling M; Rubino R; Nicol CJB; Wang W; Yang X
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612874
[TBL] [Abstract][Full Text] [Related]
9. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ for cancer therapy: opportunities and challenges (review).
Guo L; Teng L
Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
[TBL] [Abstract][Full Text] [Related]
11. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
12. Recent insight into the role and therapeutic potential of YAP/TAZ in gastrointestinal cancers.
Wang Y; Chen H; Yu J; Kang W; To KF
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188787. PubMed ID: 36041574
[TBL] [Abstract][Full Text] [Related]
13. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancers.
Gu Y; Wang Y; Sha Z; He C; Zhu Y; Li J; Yu A; Zhong Z; Wang X; Sun Y; Lan F; Yu FX
Cell Rep; 2022 Aug; 40(9):111296. PubMed ID: 36044856
[TBL] [Abstract][Full Text] [Related]
15. The Hippo signaling pathway provides novel anti-cancer drug targets.
Bae JS; Kim SM; Lee H
Oncotarget; 2017 Feb; 8(9):16084-16098. PubMed ID: 28035075
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
17. The Hippo Pathway: Biology and Pathophysiology.
Ma S; Meng Z; Chen R; Guan KL
Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
[TBL] [Abstract][Full Text] [Related]
18. A gain-of-functional screen identifies the Hippo pathway as a central mediator of receptor tyrosine kinases during tumorigenesis.
Azad T; Nouri K; Janse van Rensburg HJ; Maritan SM; Wu L; Hao Y; Montminy T; Yu J; Khanal P; Mulligan LM; Yang X
Oncogene; 2020 Jan; 39(2):334-355. PubMed ID: 31477837
[TBL] [Abstract][Full Text] [Related]
19. [Emerging roles of Hippo signaling pathway in gastrointestinal cancers and its molecular mechanisms].
Huang Y; Yang F; Zhou T; Xie S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(1):35-43. PubMed ID: 32621422
[TBL] [Abstract][Full Text] [Related]
20. CDK7 regulates organ size and tumor growth by safeguarding the Hippo pathway effector Yki/Yap/Taz in the nucleus.
Cho YS; Li S; Wang X; Zhu J; Zhuo S; Han Y; Yue T; Yang Y; Jiang J
Genes Dev; 2020 Jan; 34(1-2):53-71. PubMed ID: 31857346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
